Aignostics Raises €14m Series A to Advance AI-powered Pathology
Spin-off from Charité developing sophisticated AI models to improve understanding, diagnosis and treatment of complex diseases
19-Sep-2022 -
Aignostics, a spin-off from Charité – Universitätsmedizin Berlin, developing novel digital pathology solutions with “Explainable AI” for pharmaceutical research and diagnostics, today announced the closing of an oversubscribed €14m Series A financing round. Wellington Partners led the round, ...
artificial intelligence
machine learning
pathology
+1